Journal of Head & Neck Physicians and Surgeons : Table of Contents

Users Online: 426

Article Cited by others

REVIEW ARTICLE

Evolving role of immunotherapy in head-and-neck cancers: A systemic review

Chanana Raajit, Noronha Vanita, Joshi Amit, Patil Vijay, Prabhash Kumar

Year : 2018| Volume: 6| Issue : 1 | Page no: 2-11

This article has been cited by

1	Shame and Stigma Over Long-Term Survival in Postoperative Cases of Head and Neck Cancer

	Atul Kumar Goyal, Jaimanti Bakshi, Naresh K. Panda, Rakesh Kapoor, Dharam Vir, Krishan Kumar, Pankaj Aneja

	Journal of Maxillofacial and Oral Surgery. 2023;

	[Pubmed] [Google Scholar] [DOI]

2	First-in-human phase 1 study of budigalimab, an anti-PD-1 inhibitor, in patients with non-small cell lung cancer and head and neck squamous cell carcinoma

	Antoine Italiano,Philippe A. Cassier,Chia-Chi Lin,Tuomo Alanko,Katriina J. Peltola,Anas Gazzah,Her-Shyong Shiah,Emiliano Calvo,Andrés Cervantes,Desamparados Roda,Diego Tosi,Bo Gao,Michael Millward,Lydia Warburton,Minna Tanner,Stefan Englert,Stacie Lambert,Apurvasena Parikh,Daniel E. Afar,Gregory Vosganian,Victor Moreno

	Cancer Immunology, Immunotherapy. 2021;

	[Pubmed] [Google Scholar] [DOI]

3	Immunoregulatory Potential of Exosomes Derived from Cancer Stem Cells

	Shannon M Clayton,Joehleen Archard,Joseph Wagner,D Gregory Farwell,Arnaud F Bewley,Angela Beliveau,Andrew C Birkeland,Shyam Rao,Marianne Abouyared,Peter Belafsky,Johnathon D Anderson

	Stem Cells and Development. 2019;

	[Pubmed] [Google Scholar] [DOI]

4	Immunotherapy and its advances in the management of head-and-neck cancer

	SajadAhmad Buch,Laxmikanth Chatra

	CHRISMED Journal of Health and Research. 2019; 6(4): 199

	[Pubmed] [Google Scholar] [DOI]